Continuous Hemoglobin Monitoring in Pediatric Transplant

NCT00958984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2023-09-06

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical utility of non-invasive monitoring of Hemoglobin (Hgb) and Plethysmograph Variability Index (PVI) values during the intraoperative period of visceral solid organ transplantation in children. Hemoglobin values reflect oxygen-carrying capacity of the blood and PVI reflects fluid balance and perfusion.

Conditions

  • Pediatric Solid Organ Transplant

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • James Sullivan, MD · University of Nebraska

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-11
Primary Completion
2011-08-01
Completion
2011-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00958984 on ClinicalTrials.gov